Is Trimi Legit? What Our Registry Shows (2026)

Is Trimi a real, safe GLP-1 telehealth company? Verified pricing history, its stated 6-month weight-loss guarantee, named clinical network, states served, and Trustpilot’s suppressed rating, sourced from RangeYourself’s dated registry.

By RangeYourselfLast verified August 21, 2026

Yes, Trimi is a real, operating GLP-1 telehealth company. RangeYourself has independently verified its pricing directly against its own site since July 14, 2026, most recently on August 21, 2026, and its refund/cancellation terms and states served are published on its own site, the evidence for that verdict is the dated verification trail below, not a claim we're asking you to take on faith.

Before you buy: Trimi's Trustpilot rating is currently unavailable. Trustpilot has suppressed the aggregate score (Trustpilot displays a guideline-breach warning on this profile: “This company’s rating is unavailable due to a breach of our guidelines.” No numeric rating or review count is shown, individual reviews are still visible on the page, but Trustpilot has suppressed the aggregate score.). Individual reviews are still visible on the profile. Read "What the records show" below before you decide.

How long we’ve tracked Trimi

RangeYourself first recorded a verified price for Trimi on July 14, 2026, sourced directly from Trimi’s own site. Since then we’ve logged 2 dated price checks on this program, most recently August 21, 2026. That dated trail , not a one-time snapshot, is what a legitimacy check on a telehealth program should rest on.

Pricing verification history

July 14, 2026: $99/mobaseline snapshot, price-history tracking began 2026-07-14; seeded from the current verified price only (no prior prices invented)
August 21, 2026: $99/moPrice-only recheck, first-party static fetch of trytrimi.com/treatments/semaglutide and /treatments/tirzepatide. Unchanged: semaglutide $99/mo annual plan ($1,188 billed yearly); tirzepatide $125/mo annual plan ($1,500 billed yearly).

Refund and cancellation policy

Trimi’s own stated policy: Conditional 6-month weight-loss guarantee: 'Follow your plan for 6 months and if you don’t lose weight, you can request a refund. Terms apply.'

Guarantee: 6-month, Follow your plan for 6 months and if you don't lose weight, you can request a refund. Terms apply. This is Trimi’s own policy, not a promise from RangeYourself, and it is not a guarantee of any individual’s weight-loss outcome. Confirm current terms directly with Trimi before enrolling.

Price and terms on file

Price: $99/mo (annual-plan rate)

Membership fee: No separate membership fee

Price last verified: August 21, 2026

Pharmacy and compounding evidence

Trimi states its medication is 'prepared per individual prescription by state-licensed 503A compounding pharmacies', a 503A designation without naming a specific pharmacy, and identifies its clinical network as Arora Health (Sean Arora, MD, licensed in all 50 states) (trytrimi.com, verified 2026-07-14).

States served

Trimi ships to all 50 US states plus Washington, D.C., per its own site (verified August 21, 2026).

What the records show

Trimi is the one provider in our dataset with a Trustpilot rating actively suppressed for a guideline-breach warning, Trustpilot's own explanation, not our characterization, and we found no BBB listing to cross-reference. Individual reviews are still visible on the profile even though the aggregate score isn't.

Trustpilot: rating unavailable, Trustpilot displays a guideline-breach warning on this profile: “This company’s rating is unavailable due to a breach of our guidelines.” No numeric rating or review count is shown, individual reviews are still visible on the page, but Trustpilot has suppressed the aggregate score. (via Trustpilot, checked 2026-07-24)

Independently observed third-party data, not our own editorial score. Full methodology: GLP-1 Provider Reliability Report.

Verified programs that cost less than Trimi

Trimi’s own verified figure is $99/mo (annual-plan rate). Every program below carries a lower all-in monthly price that we verified on the provider’s own pricing page, ranked lowest first as of September 14, 2026.

1.Embody
$69/mo (limited-time promo), verified September 5, 2026
See pricing →

Prices are each provider’s own published all-in monthly figure at the plan term shown, verified on the date listed. RangeYourself may earn a commission from some programs; that can only break an exact tie between verified equals and never changes the price order.

See Trimi pricing → Read the full Trimi review →

Frequently asked questions

Is Trimi a real company?

Yes. RangeYourself has independently verified Trimi's pricing directly against its own site (trytrimi.com), first checked July 14, 2026 and most recently re-verified August 21, 2026, across 2 dated price checks on file, and its refund policy and states served are published on its own site.

Is Trimi FDA-approved?

No. Trimi prescribes compounded semaglutide and/or tirzepatide via state-licensed 503A pharmacies or 503B outsourcing facilities. Compounded medication is not individually FDA-approved as a finished product. The shortage-era compounding pathway ended after the FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so compounding now proceeds under the ordinary rules for individual patients.

Does Trimi offer refunds or a guarantee?

Trimi's own stated policy: Conditional 6-month weight-loss guarantee: 'Follow your plan for 6 months and if you don’t lose weight, you can request a refund. Terms apply.' This is the program's own policy, not a promise from RangeYourself, confirm current terms directly with Trimi before enrolling.

What do independent reviews show for Trimi?

Trustpilot rating unavailable, the profile carries a guideline-breach warning (checked 2026-07-24). This is third-party data, not RangeYourself's own editorial score.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. This legitimacy check reflects registry data verified through August 21, 2026 and may change.